'Major improvements' in arthritis symptoms for over half of drug trial patients

An interim trial led by Emeritus Professor Jonathan Edwards (UCL Medicine) has found dramatic improvements in over 50 per cent of arthritis patients using rituximab, a drug which suppresses antibody production.

Read: Daily Mail